Novavax, Shah Capital
Shah Capital urges Novavax shareholders to vote against three directors
Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the re-election of three directors and opposed proposals related to executive compensation, weeks after pushing for a board shakeup at the COVID-19 vaccine maker.
CORRECTED-UPDATE 3-Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against re-election of three directors on the board of the COVID-19 vaccine maker. Shah Capital, which currently owns a nearly 7.5% stake in Novavax,
Shah Capital is among the top three investors in Novavax, with a 7.5% stake that has swelled from 6.7% when it first launched its campaign against the company’s leadership last month. It had vowed to ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Shah Capital, which owns a roughly 7.5% stake in Novavax, called for shareholders to vote against re-electing three of the vaccine maker’s director nominees.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you have a high tolerance for volatility then the biotech ...
In the latest trading session, Novavax (NVAX) closed at $4.33, marking a +0.93% move from the previous day. This move outpaced the S&P 500's daily loss of 1.57%. Elsewhere, the Dow saw a downswing ...
Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price Shah Capital which owns 6.7% of Novavax ...
NEW YORK, NY / ACCESSWIRE / May 2, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class ...
Shah Capital appoints two new directors to the company's board. The hedge fund said it believes Novavax needs to adopt a more dynamic sales and marketing strategy, among other things. Loading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results